Form 4: Ingevity Director Acquires Shares via Deferred Stock Units
Insider Transaction Report
Ingevity Corp. Director J. Kevin Willis acquired 479 shares of common stock through vested deferred stock units, increasing his direct beneficial ownership to 8,779 shares.
Summary
- Director J. Kevin Willis acquired 479 shares of Ingevity Corp. common stock on January 2, 2026.
- The shares were acquired at a price of $60.09 per share.
- This acquisition represents vested deferred stock units (DSUs) that Mr. Willis elected to receive in lieu of quarterly director fees.
- These DSUs are scheduled to settle into an equal number of common stock shares upon Mr. Willis's termination of board service, as per the Company's Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan.
- Following this transaction, Mr. Willis directly beneficially owns a total of 8,779 shares of Ingevity Corp. common stock.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as a director is increasing their stake in the company, even if through a pre-arranged compensation plan, which generally signals continued confidence and alignment with shareholder interests.
Positives
- Director J. Kevin Willis increased his direct beneficial ownership in Ingevity Corp. by 479 shares, demonstrating continued alignment with shareholder interests.
- The acquisition through deferred stock units (DSUs) reflects a pre-planned and structured compensation arrangement for non-employee directors.
Future Outlook
The acquired deferred stock units are set to settle into common stock shares upon the reporting person's termination of board service, indicating a future conversion event.
Industry Context
This transaction is a routine insider filing, common for publicly traded companies where directors receive compensation in the form of equity or deferred stock units, aligning their interests with long-term shareholder value.
Stakeholder Impact
- Shareholders: The increase in director ownership aligns management interests with shareholder value, potentially fostering greater confidence.
- Employees: No direct impact mentioned.
Next Steps
- The vested deferred stock units will settle into an equal number of shares of the Company's Common Stock upon J. Kevin Willis's termination of board service.
Key Dates
| Date | Description |
|---|---|
| 01/02/2026 | Date of transaction where 479 shares of common stock were acquired. |
| 01/06/2026 | Date the Form 4 was signed by J. Kevin Willis via Mavis Huger as Attorney-in-Fact. |
Keywords
Ingevity, NGVT, Form 4, Insider Transaction, Director, Stock Acquisition, Deferred Stock Units, DSU, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.